Re: patients in clinical trial overwhelmingly prefer subcutaneous herceptin administr
I have posted about this before. Subcutaneous herceptin is now approved in the EU but Genentech reps at various meetings have told me Genentech has NO plans to even apply for approval of subcutaneous herceptin in the US with the FDA.
|